GREEN SESSION: SPY +0.68% | Range-bound

SPY opened nearly unchanged at $769.94, briefly tested $769.69, and then advanced following the 10:00 ET services report. ISM services PMI registered 54.9 versus 55.1 consensus and 55.4 previously, an objectively soft activity reading. Despite that miss, SPY was 0.55% above its pre-release level by 15:55 ET, while RSI-14 rose from 55 before the print to 60. Monday mechanics mattered: weekend headlines were largely absorbed at the open, leaving room for the market to respond to positioning and broad sector participation rather than the economic number alone.

Momentum carried SPY to $776.61 before it eased to a $774.88 close, leaving the index $1.73 below the session high but up 0.68%. Participation was broad, with 10 of 11 sectors positive; QQQ gained 0.88% and IWM advanced 0.66%. The advance was not entirely complacent, however: VIX rose to 15.52, the 10-year yield increased 3 basis points to 5.31%, and normal volume of 0.94 times average limited the conviction behind the breakout attempt.

The SHC observer remained at NO DRAWDOWN, with suppression capacity at 90 and price pressure at 9. The two forces are drifting from the drawdown event, with 101 points of combined distance remaining versus 59 points on September 28.

S&P 500 (SPY): $769.94 (Open) → $774.88 (Close) | +0.68% | Range: $769.69-$776.61 NASDAQ (QQQ): $756.20 (Close) | +0.88% Russell 2000 (IWM): $283.39 (Close) | +0.66% VIX: 15.52 (+1.37%) Volume: Normal (0.94x average)

- Danaher (DHR): +3.32% to $221.16 — Led the listed gainers as life-sciences and diagnostics exposure attracted demand during the broad rally; no separate company-specific catalyst was supplied. - Thermo Fisher Scientific (TMO): +3.28% to $676.31 — Advanced alongside Danaher, reinforcing the session’s strength in life-sciences tools rather than indicating a single-stock move. - Abbott Laboratories (ABT): +2.70% to $100.13 — Medical-device exposure outperformed as healthcare participation favored equipment and diagnostics over large pharmaceutical names. - Visa (V): +2.50% to $369.69 — Payments shares participated strongly despite the softer services reading, suggesting the tape did not treat the report as an immediate consumer-demand break. - Mastercard (MA): +2.30% to $564.96 — Tracked Visa higher as payment networks joined the broad advance; no company-specific headline was provided.

- Merck (MRK): -3.30% to $139.54 — Was the weakest listed name, showing sharp pharmaceutical underperformance even as healthcare tools advanced. - Intel (INTC): -2.63% to $116.19 — Lagged despite QQQ’s positive close, indicating company-specific or legacy-chip pressure rather than broad technology weakness. - Salesforce (CRM): -2.09% to $229.79 — Enterprise software underperformed the wider communication-services and technology participation; no discrete catalyst was supplied. - Accenture (ACN): -1.94% to $195.04 — Declined alongside software-related exposure, pointing to weakness in enterprise technology services. - Johnson & Johnson (JNJ): -1.21% to $252.92 — Joined Merck on the downside, underscoring the split between pharmaceutical names and the stronger diagnostics and medical-device group.

Materials led at +1.31%, followed by Communication Services at +1.15% and Energy at +0.99%, a cyclical leadership mix consistent with broad participation. Real Estate fell 0.37%, while Industrials added only 0.08% and Utilities gained 0.33%; rate-sensitive groups lagged as the 10-year yield reached 5.31%, keeping the session guarded despite positive breadth.

- SPY held its opening area: The session low of $769.69 remained just beneath the $769.94 open, establishing that zone as the first observed support from Monday’s range. - The intraday ceiling is clearly defined: SPY reached $776.61 but closed at $774.88, making the session high the nearest observed resistance for the next trading session. - Level-Map invalidation remains below the session: The desk’s key SPY invalidation is $756.59; the temporary-dips regime remains valid while that level holds. - Leadership stayed broad across index sizes: QQQ closed at $756.20 and IWM at $283.39, but no intraday ranges were supplied for either ETF, so additional support or resistance levels are not assigned.

No verified overnight futures indications or nightly single-stock movers were supplied as of 4:30 p.m. ET. The desk’s TRH verdict remains MARKET VALUE INTACT — TEMPORARY DIPS, with P* at 27% ELEVATED; the book is structurally Phase 3 defensive but tactically expects dips to remain temporary and reversals to hold while the Level-Map invalidation remains intact and until the next tier-1 release. The event window is heavy ahead of CPI on Wednesday, October 14, so the model book uses smaller sizing into tier-1 releases and does not initiate leveraged exposure into CPI day.

A range-bound advance with broad participation, though the higher VIX, rising Treasury yield and normal volume kept the session guarded rather than fully risk-seeking.